
Popular weight-loss drugs show promising new power against debilitating migraines
Fox News
GLP-1 drugs show promise for migraine relief, reducing headache days from 20 to 11 per month in adults with obesity, with benefits appearing within two weeks regardless of weight loss.
"Most patients felt better within the first two weeks and reported quality of life improved significantly." Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
Presented at the European Academy of Neurology Congress in Helinski, Finland, on June 21, the results suggest promising future uses of the popular obesity and diabetes drugs.
More Related News













